The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

American Journal of Hematology. 2019 Feb;94(2):E58-E61.

View abstract

Authors

Khorana AA, McCrae K, Milentijevic D, McCormick N, Laliberté F, Crivera C, Lefebvre P, Lejeune D, Rozjabek H, Schein J, Streiff MB